DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Doxylamine succinateis the generic ingredient in eight branded drugs marketed by Pfizer, Sanofi Aventis Us, Par Pharm, Copley Pharm, LNK, Perrigo, Quantum Pharmics, Chattem, Duchesnay, Actavis Labs Fl Inc, and Par Pharm Inc, and is included in thirteen NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are fourteen drug master file entries for doxylamine succinate. Thirty-one suppliers are listed for this compound.
Recent Clinical Trials for doxylamine succinate
Identify potential brand extensions & 505(b)(2) entrants
|Grünenthal GmbH||Phase 1|
|Grünenthal, S.A.||Phase 1|
|Azidus Brasil||Phase 3|